| 000 | 01863 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517185606.0 | ||
| 264 | 0 | _c20180104 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2017.11.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yuan | |
| 245 | 0 | 0 |
_aDesign, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cJan 2018 |
||
| 300 |
_a137-149 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDucks |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B Virus, Duck _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aMonosaccharides _xchemical synthesis |
| 650 | 0 | 4 |
_aNucleosides _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTriazoles _xchemical synthesis |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aPeng, Youmei | |
| 700 | 1 | _aLu, Jingjing | |
| 700 | 1 | _aWang, Jingwen | |
| 700 | 1 | _aMa, Haoran | |
| 700 | 1 | _aSong, Chuanjun | |
| 700 | 1 | _aLiu, Bingjie | |
| 700 | 1 | _aQiao, Yan | |
| 700 | 1 | _aYu, Wenquan | |
| 700 | 1 | _aWu, Jie | |
| 700 | 1 | _aChang, Junbiao | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 143 _gp. 137-149 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2017.11.028 _zAvailable from publisher's website |
| 999 |
_c27824522 _d27824522 |
||